Home    Back

 Drug    DrugBank | All Description Patterns

   e.g. "Sirolimus", "Adalimumab"

A    B    C    D    E    F    G    H     I     J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    other

33 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   Drug (Description in trials)   DrugBank   KEGG DRUG *   KEGG GENES * 
 [Number of genes] 		  KEGG PATHWAY 
 [Number of pathways] 		  Disease ID * 
 [Number of diseases] 
 1   Actimmune   Interferon gamma-1b   D00747   [2] IFNGR1, IFNGR2   [19] Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease (IBD), Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Salmonella infection, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis   [1]
326 
 2   Actimmune registry   -   -   -   -   [1]
326 
 3   Ap1903   Ap1903   -   -   -   [3]
60,
285,
326 
 4   Bpx-501 t cells   -   -   -   -   [4]
65,
284,
285,
326 
 5   Busulfan   Busulfan   D00248   -   -   [13]
19,
20,
28,
36,
49,
51,
60,
65,
164,
274,
284,
285,
326 
 6   Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen)   Cyclophosphamide   D00287, D07760   -   -   [1]
326 
 7   Calcitriol   Calcitriol   D00129   [1] VDR   [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   [8]
37,
46,
49,
66,
96,
158,
235,
326 
 8   Cald hr-d (high-risk, regimen c)   -   -   -   -   [4]
19,
20,
234,
326 
 9   Cald hr-d (high-risk, regimen d)   -   -   -   -   [4]
19,
20,
234,
326 
 10   Cald sr-a (standard-risk, regimen a)   -   -   -   -   [4]
19,
20,
234,
326 
 11   Cald sr-b (standard-risk, regimen b)   -   -   -   -   [4]
19,
20,
234,
326 
 12   Campath, busulfan, clofarabine   Clofarabine   D03546   [3] POLA1, POLA2, RRM1   [6] DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   [1]
326 
 13   Campath-1h   Alemtuzumab   D02802   -   -   [6]
19,
20,
60,
234,
285,
326 
 14   Cd34+ enriched, t cell depleted donor stem cell product   -   -   -   -   [1]
326 
 15   Clofarabine   Clofarabine   D03546   [3] POLA1, POLA2, RRM1   [6] DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   [9]
19,
20,
40,
46,
49,
60,
96,
234,
326 
 16   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   [43]
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 17   Cyclophosphamide 30   Cyclophosphamide   D00287, D07760   -   -   [3]
65,
285,
326 
 18   Cyclophosphamide 40   Cyclophosphamide   D00287, D07760   -   -   [3]
65,
285,
326 
 19   Cyclosporin   Ciclosporin   D00184   [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   [30] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   [16]
14,
38,
39,
49,
53,
56,
60,
62,
63,
97,
113,
164,
222,
223,
274,
326 
 20   Cyclosporin, methotrexate (gvhd prophylaxis)   Methotrexate   D00142, D02115   [2] DHFR, DHFR2   [4] Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   [1]
326 
 21   Fludarabine   Fludarabine   D01907, D07966   [1] RRM1   [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   [17]
13,
28,
36,
46,
49,
51,
60,
61,
62,
65,
85,
96,
164,
283,
284,
285,
326 
 22   Fludarabine monophosphate   Fludarabine   D01907, D07966   [1] RRM1   [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   [4]
49,
65,
284,
326 
 23   Hematopoetic stem cell transplantation   -   -   -   -   [5]
19,
65,
120,
160,
326 
 24   Imd preparative regimen   -   -   -   -   [4]
19,
20,
234,
326 
 25   Interferon gamma   -   -   -   -   [2]
65,
326 
 26   Interferon gamma-1b   -   -   -   -   [7]
65,
85,
90,
228,
299,
301,
326 
 27   Methotrexate   Methotrexate   D00142, D02115   [2] DHFR, DHFR2   [4] Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   [33]
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 28   Osteopetrosis haploidentical only preparative regimen   -   -   -   -   [4]
19,
20,
234,
326 
 29   Osteopetrosis only preparative regimen   -   -   -   -   [4]
19,
20,
234,
326 
 30   Rhpth   Parathyroid hormone   D05364   [2] PTH1R, PTH2R   [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action   [3]
70,
235,
326 
 31   Rimiducid   -   -   -   -   [5]
19,
65,
284,
285,
326 
 32   Stem cell transplantation   -   -   -   -   [9]
13,
19,
20,
46,
65,
90,
164,
234,
326 
 33   Systemic chemotherapy and antibodies   -   -   -   -   [2]
62,
326 

Back to top